Endometrial hyperplasia: without atypia and with atypia

The article analyzes and presents data for the last 70 years from the PubMed database on endometrial hyperplasia (EH), which is one of the leaders in the structure of gynecological diseases and the main predictor of endometrial cancer (EC). The chronicle of the EH classification is highlighted with...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Maksim A. Sabantsev, Svetlana V. Shramko, Vladimir G. Levchenko, Oleg A. Volkov, Tatyana V. Tretyakova
Formato: article
Lenguaje:RU
Publicado: IP Berlin A.V. 2021
Materias:
Acceso en línea:https://doaj.org/article/5720f9cf9c2e46548e80c415663b46ec
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5720f9cf9c2e46548e80c415663b46ec
record_format dspace
spelling oai:doaj.org-article:5720f9cf9c2e46548e80c415663b46ec2021-12-02T19:22:24ZEndometrial hyperplasia: without atypia and with atypia2079-56962079-583110.26442/20795696.2021.1.200666https://doaj.org/article/5720f9cf9c2e46548e80c415663b46ec2021-03-01T00:00:00Zhttps://gynecology.orscience.ru/2079-5831/article/viewFile/63625/46623https://doaj.org/toc/2079-5696https://doaj.org/toc/2079-5831The article analyzes and presents data for the last 70 years from the PubMed database on endometrial hyperplasia (EH), which is one of the leaders in the structure of gynecological diseases and the main predictor of endometrial cancer (EC). The chronicle of the EH classification is highlighted with a focus on changing the designation and relevance of adenomatous EH. It is shown how the current classification of EH, due to the fact that a large number of synonyms is limited by two options, allows to maximize the reproducibility of the diagnosis, improve the interaction of the obstetrician-gynecologist with the pathologist and reduce the treatment inefficiency. The results of modern studies on the prevalence and risk factors of EH and EC differ from previously accepted ones and destroy the Bohman triad. The risks of EH development with tamoxifen and menopausal hormone therapy are determined. The data of current research methods aimed at the diagnosis of EH and EC are indicated. The differences in etiopathogenesis, prevalence, diagnosis, risk factors for development and progression to the malignant process presented in the review represent two types of EH (without atypia and with atypia) as completely different endometrial diseases included in the same classification.Maksim A. SabantsevSvetlana V. ShramkoVladimir G. LevchenkoOleg A. VolkovTatyana V. TretyakovaIP Berlin A.V. articleadenomatosisendometrial cancerendometrial hyperplasiaglandular intraepithelial neoplasiahysteroscopypredictors of endometrial cancerreproducibility of the diagnosistamoxifenGynecology and obstetricsRG1-991RUГинекология, Vol 23, Iss 1, Pp 18-24 (2021)
institution DOAJ
collection DOAJ
language RU
topic adenomatosis
endometrial cancer
endometrial hyperplasia
glandular intraepithelial neoplasia
hysteroscopy
predictors of endometrial cancer
reproducibility of the diagnosis
tamoxifen
Gynecology and obstetrics
RG1-991
spellingShingle adenomatosis
endometrial cancer
endometrial hyperplasia
glandular intraepithelial neoplasia
hysteroscopy
predictors of endometrial cancer
reproducibility of the diagnosis
tamoxifen
Gynecology and obstetrics
RG1-991
Maksim A. Sabantsev
Svetlana V. Shramko
Vladimir G. Levchenko
Oleg A. Volkov
Tatyana V. Tretyakova
Endometrial hyperplasia: without atypia and with atypia
description The article analyzes and presents data for the last 70 years from the PubMed database on endometrial hyperplasia (EH), which is one of the leaders in the structure of gynecological diseases and the main predictor of endometrial cancer (EC). The chronicle of the EH classification is highlighted with a focus on changing the designation and relevance of adenomatous EH. It is shown how the current classification of EH, due to the fact that a large number of synonyms is limited by two options, allows to maximize the reproducibility of the diagnosis, improve the interaction of the obstetrician-gynecologist with the pathologist and reduce the treatment inefficiency. The results of modern studies on the prevalence and risk factors of EH and EC differ from previously accepted ones and destroy the Bohman triad. The risks of EH development with tamoxifen and menopausal hormone therapy are determined. The data of current research methods aimed at the diagnosis of EH and EC are indicated. The differences in etiopathogenesis, prevalence, diagnosis, risk factors for development and progression to the malignant process presented in the review represent two types of EH (without atypia and with atypia) as completely different endometrial diseases included in the same classification.
format article
author Maksim A. Sabantsev
Svetlana V. Shramko
Vladimir G. Levchenko
Oleg A. Volkov
Tatyana V. Tretyakova
author_facet Maksim A. Sabantsev
Svetlana V. Shramko
Vladimir G. Levchenko
Oleg A. Volkov
Tatyana V. Tretyakova
author_sort Maksim A. Sabantsev
title Endometrial hyperplasia: without atypia and with atypia
title_short Endometrial hyperplasia: without atypia and with atypia
title_full Endometrial hyperplasia: without atypia and with atypia
title_fullStr Endometrial hyperplasia: without atypia and with atypia
title_full_unstemmed Endometrial hyperplasia: without atypia and with atypia
title_sort endometrial hyperplasia: without atypia and with atypia
publisher IP Berlin A.V.
publishDate 2021
url https://doaj.org/article/5720f9cf9c2e46548e80c415663b46ec
work_keys_str_mv AT maksimasabantsev endometrialhyperplasiawithoutatypiaandwithatypia
AT svetlanavshramko endometrialhyperplasiawithoutatypiaandwithatypia
AT vladimirglevchenko endometrialhyperplasiawithoutatypiaandwithatypia
AT olegavolkov endometrialhyperplasiawithoutatypiaandwithatypia
AT tatyanavtretyakova endometrialhyperplasiawithoutatypiaandwithatypia
_version_ 1718376736977059840